C O M M U N I C A T I O N S
(11) Wei, P.; Atwood, D. A. Inorg. Chem. 1998, 37, 4934.
further positive attribute of this system is that these reactions can
be conducted at room temperature. Unlike the synthetic enzyme
models, the C-O cleavage appears to occur at only one metal site.
For example, preliminary results show that the compound N, -tert-
butyl (salicylideneimine) dealkylates trimethyl phosphate. Thus, this
might be a general reaction for any type of chelate.
The phosphates dealkylated in this report may be viewed as
models for the nerve agent Sarin and the pesticide chloropyrifos
since they have similar P-O-C units. Thus, chelated boron
bromides appear to be promising candidates for the decontamination
of chemical warfare agents such as VX and Sarin gas under organic
conditions. More specifically, they may be more efficient than
conventional decontamination systems that use hydroxide sources.21
(12) Experimental details for 1 and 2: Salpen(tBu)[BBr2]2 (1). To a stirring
solution of Salpen(tBu)[B(OMe)2]2 (3.0 g, 4.62 mmol) in toluene (50 mL)
was added 1M BBr3 in heptane (6.24 mL, 6.24 mmol). The reaction
mixture was stirred for 24 h. The solvent was removed and the solid
remaining behind was washed with 10 mL of hexanes. Filtration and
vacuum-drying afforded Salpen(tBu)[BBr2]2. Yield: 3.28 g (88%); mp
1
282-285 °C dec. H NMR (CDCl3): δ 1.25 [s, 18H, C(CH3)3], 1.47 [s,
18H, C(CH3)3], 2.88 [m, 2H, CH2], 4.12 [m, 4H, NCH2], 7.30 [d, 2H,
C6H2], 7.76 [d, 2H, C6H2], 8.53 [s, 2H, CHN]. 11B NMR (CDCl3): δ
-0.57 (w1/2 ) 78.2 Hz). IR(cm-1): 2963(s), 2870(w), 1626(s), 1575(s),
1472 (m), 1438(m), 1395(m), 1364(s), 1339(m), 1279(m), 1217(w). 1077-
(w), 1027(w), 904(w), 846(w), 769(w), 668(m), 641(m). MS: 766(Mx
- Br, 20), 686(Mx - 2Br, 5), 606(Mx - 3Br, 100). Anal. Calcd for
B2C33H48N2O2Br4: C 47.03(46.96), H 5.74(5.68), N 3.33(3.32). Salben-
(tBu)[BBr2]2 (2). To a stirring solution of Salben(tBu)[B(OMe)2]2 (1.0 g,
1.51 mmol) in toluene (50 mL) was added 1 M BBr3 in heptane (2.04
mL, 2.04 mmol). The reaction mixture was stirred for 18 h at room
temperature. The solution was concentrated to 10 mL, filtered, and dried.
1
Yield: 0.96 g (76%); mp: 279-280 °C dec. H NMR (CDCl3): δ 1.27
Acknowledgment. This work was supported by the National
Science Foundation NSF-CAREER award (CHE 9816155). L.J.D.
was supported by the NSF-REU program (CHE -0097668) in the
summer of 2001. NMR instruments used in this research were
obtained with funds from the CRIF program of the National Science
Foundation (CHE 997841) and from the Research Challenge Trust
Fund of the University of Kentucky.
[s, 18H, C(CH3)3], 1.42 [s, 18H, C(CH3)3], 2.21 [m, 4H, CH2], 4.08 [m,
4H, NCH2], 7.22 [d, 2H, C6H2], 7.78 [d, 2H, C6H2], 8.24 [s, 2H, CHN].
11B NMR (CDCl3): δ -0.40 (w1/2 ) 92.7 Hz). IR (cm-1): 2953(s), 2900-
(m), 2870(w), 1627(s), 1573(s), 1469(m), 1440(m), 1395(w), 1362(w),
1253(m), 1220(m), 1136(w), 1083(w), 1024(m), 863(m), 768(w), 641-
(w). MS: 780(Mx - Br, 100), 700(Mx - 2Br, 50), 620(Mx - 3Br,
40), 540(Mx - 4Br, 10). Anal. Calcd for B2C34H50N2O2Br4: C 47.66
(47.84), H 5.89 (6.22), N 3.27 (3.22).
(13) Keizer, T. S.; Parkin, S.; Atwood, D. A. J. Can. Chem. Submitted.
(14) X-ray data for 2 were collected on a Nonius CCD unit employing Mo
KR radiation. The structures were refined using the Siemens software
package SHELXTL 4.0. All of the non-hydrogen atoms were refined
anisotropically. The hydrogen atoms were put into calculated positions.
Absorption corrections were not employed. X-ray data for 2: yellow
crystals (0.2 mm × 0.2 mm × 0.16 mm), formula C48 H66 B2 Br4 N2 O2
FW 1044.29, monoclinic, P21/c, a ) 14.0520(10) Å, b ) 30.708(2) Å, c
) 12.2780(10) Å, â ) 108.733(10)°, V ) 5017.4(6) Å3, Z ) 4, data
8848, parameters 553, R1 ) 0.0486 (for I > 2RI), wR2 ) 0.0755, GOF
(on F2) ) 1.078.
Supporting Information Available: X-ray crystallographic data
for 2 (PDF). This material is available free of charge via the Internet
References
(1) Ember, L. Chem. Eng. News 1999, 77(35), 11.
(2) (a) David, M. D.; Seiber, J. N. EnViron. Pollution 1999, 105, 121. (b)
(15) Wei, P.; Keizer, T. S.; Atwood, D. A. Inorg. Chem. 1999, 38, 3914.
Hileman, B. Chem. Eng. News 2000, 78(24), 11.
(16) Brown, D. S.; Carmalt, C. J.; Cowley, A. H.; Decken, A.; Isom, H. S.
(3) Recent examples: Olivanen, M.; Kuusela, S,; Lonnberg, H. Chem. ReV.
1998, 98, 961; Blasko, A.; Bruice, T. C. Acc. Chem. Res. 1999, 32, 475;
Bazzicalupi, C.; Bencini, A.; Berni, E.; Bianchi, A.; Fedi, V.; Fusi, V.;
Giorgi, C.; Paoletti, P.; Valtancoli, B. Inorg. Chem. 1999, 38, 4115.
(4) Gajda, T.; Du¨pre, Y.; To¨ro¨k, I.; Harmer, J.; Schweiger, A.; Sander, J.;
Kuppert, D.; Hegetschweiler, K. J. Am. Chem. Soc. 2001, 123, 4918.
(5) (a) Jones, D. R.; Lindoy, L. F.; Sargeson, A. M. J. Am. Chem. Soc. 1984,
106, 7807. (b) Vance, D. H.; Czarnik, A. W. J. Am. Chem. Soc. 1993,
115, 12165.
Heteroat. Chem. 1998, 9, 79.
(17) Dealkylation of the phosphate: In a NMR tube, phosphate was added to
a equimolar solution of the catalyst (1 or BBr3) in CDCl3 and held at
1
room temperature for 30 min. The reaction was monitored by H NMR.
(18) In a NMR tube, 5 equiv of THF was added to a solution of 1 in CDCl3
giving a 11B NMR resonance of 4.28 ppm. It is shifted downfield from 1
by 4.85 ppm, indicating the displacement of Br by THF and formation of
a cation.
(19) In a NMR tube, 3 equiv of BBr3 was added to a solution of 1 in CDCl3.
11B NMR: δ 23.10, -0.42, -21.60. Indicating the formation of BBr4
(-21.60) and Salpen(tBu)[BBr2(BBr)+] (-0.42 and 23.40).
(20) Catalytic dealkylation of the phosphate: In a NMR tube, equimolar
amounts of (MeO)3P(O) and BBr3 were added to a solution of Salpen-
(tBu)[B(OMe)2]2 in CDCl3 in the ratio of 20:1 of phosphate to borate and
held at room temperature. The reaction was monitored by 1H NMR. A
white precipitate formed during the reaction and is a type of boron
phosphate compound with no ligand present.
(6) (a) McCue, K. P.; Morrow, J. R. Inorg. Chem. 1999, 38, 6136. (b) Scrimin,
P.; Ghirlanda, G.; Tecilla, P.; Moss, R. A. Langmuir 1996, 12, 6235.
(7) (a) Kaminskaia, N. V.; He, C.; Lippard, S. J. Inorg. Chem. 2000, 39,
3365. (b) Yamami, M.; Furutachi, H.; Yokoyama, T.; Okawa, H. Inorg.
Chem. 1998, 37, 6832. (c) Chapman, W. H.; Breslow, R. J. Am. Chem.
Soc. 1995, 117, 5462. (d) Molenveld, P.; Kapsabelis, S.; Engbersen, J. F.
J.; Reinhoudt, D. N. J. Am. Chem. Soc. 1997, 119, 2948.
(8) (a) Benton, F. L.; Dillon, T. E. J. Am. Chem. Soc. 1942, 64, 1128. (b)
Ranu, B. C.; Bhar, S. Org. Prep. Proced. Int. 1996, 28(4), 371.
(9) Kim, S.; Park, J. H. J. Org. Chem. 1988, 53, 3111.
(10) Salpen(tBu) ) (N,N′-propylenebis(3,5-di-tert-butyl(2-hydroxy)benzyliden-
imine), Salben(tBu) ) (N,N′-butylenebis(3,5-di-tert-butyl(2-hydroxy)-
benzylidenimine).
(21) Yang, Y.-C. Acc. Chem. Res. 1999, 32, 109.
JA017360M
9
J. AM. CHEM. SOC. VOL. 124, NO. 9, 2002 1865